NCT05692089Completed
Incidence of Infective Endocarditis in End Stage Renal Disease Patients on Hemodialysis by Transesophageal Echocardiography in Assuit University Hospital
Source: ClinicalTrials.gov · Last updated 31 Jan 2024
Brief summary (registry, in English)
1. To detect in more detail the incidence of infective endocarditis in patients with end stage renal disease (ESRD) on hemodialysis. 2. To compare the relationship between different forms of haemodialysis access type and the related incidence of infective endocarditis. 3. To determine individual risk factors, including type of vascular haemodialysis access, previous valve lesion and immunocompromised patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 11 Jan 2023
- Start date
- 1 Feb 2023
- Primary completion date
- 3 Sept 2023
- Lead sponsor
- Assiut University
- Diseases
- Chronic kidney disease
- NCT number
- NCT05692089
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 1 Feb 2023 to the primary completion date, 3 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any patient with sepsis due to causes other than infected vascular access.
Who the study is looking for
- Incidence of infective endocarditis in ESRD that on hemodialysis.
- Must be fit for Transoesophageal ECHO.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Medicine Assiut University Coordinator of this site? Confirm its status | Asyut | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.